A Study in Non-Small Cell Lung Cancer

Clinical trial NCT01232452 · COMPLETED

Trial details

NCT number: NCT01232452
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Non-Small-Cell Lung Carcinoma

Start date: 2011-04-01
Primary completion: 2013-01-01
Enrollment: 172

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.